Version 2 2014-12-01, 14:09Version 2 2014-12-01, 14:09
Version 1 2014-12-01, 14:00Version 1 2014-12-01, 14:00
presentation
posted on 2014-12-01, 14:00authored byAndrew MarshAndrew Marsh, Paul C Taylor, Katherine Casey-Green, John Watkins, Donald RJ Singer
Talk delivered at Warwick Biomedical Engineering Seminar series 27 November 2014. Develops a theme emerging from a review in 2010:
J Watkins, A Marsh, P C Taylor, D R J Singer Therapeutic Delivery, 2010, 1, 651-665
"Continued adherence to a single-drug single-target paradigm will limit the ability of chemists to contribute to advances in personalized medicine, whether they be in discovery or delivery"